Status:

COMPLETED

Effect of the Atalante Exoskeleton on Standing and Walking in Individuals With Paraplegia: A Prospective Controlled-Environment Study in a Rehabilitation Context

Lead Sponsor:

Centre Hospitalier Universitaire de Nīmes

Conditions:

Paraplegia, Complete

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical study aims to evaluate the feasibility, safety, and acceptability of the Atalante robotic exoskeleton, developed by Wandercraft, within a functional rehabilitation protocol for individua...

Detailed Description

Background and Rationale Complete paraplegia, resulting from spinal cord injury, is a major neurological condition involving irreversible loss of lower limb function. Given the limitations of neuromot...

Eligibility Criteria

Inclusion

  • Complete spinal cord injury (ASIA A classification)
  • Lesion level at or below T6
  • Injury occurred more than 6 months prior to enrollment (chronic/stabilized injury)
  • Ability to maintain upright posture without symptomatic orthostatic hypotension
  • Joint range of motion compatible with wearing the exoskeleton
  • Anthropometric dimensions compatible with the device, including:
  • Body weight less than 90 kg

Exclusion

  • Spasticity greater than 3 on the Modified Ashworth Scale
  • Joint limitations incompatible with exoskeleton use
  • Spinal instability
  • Cognitive or psychiatric disorders affecting protocol adherence
  • Recent dermatological conditions
  • History of fragility fractures in the lower limbs within the past 2 years
  • Presence of 5 or more fracture risk factors according to Craven et al., including:
  • Injury older than 10 years
  • Thoracic-level lesion
  • Absence of regular weight-bearing activity
  • Low spasticity
  • Body Mass Index (BMI) \< 20
  • Cardiopulmonary contraindications to physical effort
  • Pregnancy or breastfeeding

Key Trial Info

Start Date :

January 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT06941896

Start Date

January 1 2017

End Date

September 1 2019

Last Update

April 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CMPR APAJH Pionsat

Pionsat, Auvergne, France, 63330